460 related articles for article (PubMed ID: 34395525)
1. Prognostic Prediction, Immune Microenvironment, and Drug Resistance Value of Collagen Type I Alpha 1 Chain: From Gastrointestinal Cancers to Pan-Cancer Analysis.
Liu Y; Xue J; Zhong M; Wang Z; Li J; Zhu Y
Front Mol Biosci; 2021; 8():692120. PubMed ID: 34395525
[No Abstract] [Full Text] [Related]
2. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
3. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
4. Identifies microtubule-binding protein
Wang W; Zhang J; Wang Y; Xu Y; Zhang S
Comput Struct Biotechnol J; 2022; 20():3322-3335. PubMed ID: 35832625
[TBL] [Abstract][Full Text] [Related]
5. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766
[No Abstract] [Full Text] [Related]
6. Pan-Cancer Integrated Analysis Identification of SASH3, a Potential Biomarker That Inhibits Lung Adenocarcinoma Progression.
Chen X; Yuan Y; Ren W; Zhou F; Huang X; Pu J; Niu X; Jiang X
Front Oncol; 2022; 12():927988. PubMed ID: 35756681
[TBL] [Abstract][Full Text] [Related]
7. Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy.
Zhang J; Wang K; Hainisayimu T; Li H
Oxid Med Cell Longev; 2022; 2022():9614819. PubMed ID: 36046686
[TBL] [Abstract][Full Text] [Related]
8. HHLA2 Used as a Potential Prognostic and Immunological Biomarker and Correlated with Tumor Microenvironment in Pan-Cancer.
Yang Z; Xu D; Ye X; Lin X; Zhang M; Su Y; Xie Q; Ni W
Biomed Res Int; 2022; 2022():3924400. PubMed ID: 35252444
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of zinc and ring finger 3 in prognostic value and pan-cancer immunity.
Liu M; Zhao H; Peng S; Wu Y; Liu Y; Sun W; Zen K; Sun X
FASEB J; 2024 Mar; 38(5):e23523. PubMed ID: 38457275
[TBL] [Abstract][Full Text] [Related]
10. PreMSIm: An R package for predicting microsatellite instability from the expression profiling of a gene panel in cancer.
Li L; Feng Q; Wang X
Comput Struct Biotechnol J; 2020; 18():668-675. PubMed ID: 32257050
[TBL] [Abstract][Full Text] [Related]
11. The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z
Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502
[TBL] [Abstract][Full Text] [Related]
12. Differential Expression of the
Hu J; Xu J; Feng X; Li Y; Hua F; Xu G
Front Cell Dev Biol; 2021; 9():700661. PubMed ID: 34631699
[TBL] [Abstract][Full Text] [Related]
13. Role of PRDM1 in Tumor Immunity and Drug Response: A Pan-Cancer Analysis.
Shen L; Chen Q; Yang C; Wu Y; Yuan H; Chen S; Ou S; Jiang Y; Huang T; Ke L; Mo J; Feng Z; Zhou P; Fan W
Front Pharmacol; 2020; 11():593195. PubMed ID: 33384601
[No Abstract] [Full Text] [Related]
14. A pan-cancer analysis revealing the role of TIGIT in tumor microenvironment.
Wen J; Mao X; Cheng Q; Liu Z; Liu F
Sci Rep; 2021 Nov; 11(1):22502. PubMed ID: 34795387
[TBL] [Abstract][Full Text] [Related]
15. Pan-Cancer Analysis Revealed
Liu J; Wang Y; Yin J; Yang Y; Geng R; Zhong Z; Ni S; Liu W; Du M; Yu H; Bai J
J Oncol; 2022; 2022():3477148. PubMed ID: 35069733
[TBL] [Abstract][Full Text] [Related]
16. CXCL11 Correlates with Immune Infiltration and Impacts Patient Immunotherapy Efficacy: A Pan-Cancer Analysis.
Li Y; Han S; Wu B; Zhong C; Shi Y; Lv C; Fu L; Zhang Y; Lang Q; Liang Z; Yu Y; Tian Y
Front Immunol; 2022; 13():951247. PubMed ID: 35935945
[TBL] [Abstract][Full Text] [Related]
17. Pan-cancer analysis of necroptosis-related gene signature for the identification of prognosis and immune significance.
Ma J; Jin Y; Gong B; Li L; Zhao Q
Discov Oncol; 2022 Mar; 13(1):17. PubMed ID: 35312867
[TBL] [Abstract][Full Text] [Related]
18. Pan-Cancer Molecular Characterization of m
Zhu J; Xiao J; Wang M; Hu D
Front Oncol; 2020; 10():618374. PubMed ID: 33585244
[TBL] [Abstract][Full Text] [Related]
19. Roles of HMGBs in Prognosis and Immunotherapy: A Pan-Cancer Analysis.
Lin T; Zhang Y; Lin Z; Peng L
Front Genet; 2021; 12():764245. PubMed ID: 34777483
[No Abstract] [Full Text] [Related]
20. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
Guo B; Wang Y; Liu W; Zhang S
Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
